Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

NCT02633176 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Docetaxel
DRUG: Capecitabine
RADIATION: Radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]